CUVITRU
TAKEDA CANADA INC
Quick answers
Is there a shortage of CUVITRU in Canada?
No. There is no current shortage of CUVITRU 200MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
GAMIMUNE N 10% (IV)
TALECRIS BIOTHERAPEUTICS INC
IMMUNE GLOBULIN INTRAVENOUS (HUMAN), 5%
TALECRIS BIOTHERAPEUTICS INC
HYPERHEP B S/D
GRIFOLS THERAPEUTICS LLC
GAMASTAN S/D
GRIFOLS THERAPEUTICS LLC
HYPERTET S/D
GRIFOLS THERAPEUTICS LLC
HEPATITIS B IG INJ
CUTTER MED & BIOL, DIVISION OF MILES CANADA LTD.
DIN
02461692
Strength
200MG
Dosage Form
Solution
Route
Subcutaneous
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from TAKEDA CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
15MG · DIN 02242572
30MG · DIN 02242573
45MG · DIN 02242574
20MG · DIN 02248811
15MG · DIN 02248810
10MG · DIN 02248809
30MG · DIN 02248813
25MG · DIN 02248812
5MG · DIN 02248808
3000UNIT · DIN 02498626
250UNIT · DIN 02498537
500UNIT · DIN 02498545